Greg L Beilhartz (Greg L Beilhartz)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Replacement Therapy

Hyaluronic Acid

Escherichia Coli

Top Venues

Science advances

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Weifan Dong, Adam Fekete, Xiaodi Chen, Hongwei Liu, Greg L Beilhartz, Xin Chen, Shahrzad Bahrampour, Yi Xiong, Qi Yang, Hongyu Zhao, Tian Kong, Malia S Morioka, Geena Jung, Ji-Eun Kim, Daniel Schramek, Peter B Dirks, Yuanquan Song, Tae-Hee Kim, Ye He, Siyi Wanggou, Xuejun Li, Roman A Melnyk, Lu-Yang Wang, Xi Huang
A designer peptide against the EAG2-Kvβ2 potassium channel targets the interaction of cancer cells and neurons to treat glioblastoma. Nature cancer (2023)
Amy E Arnold, Laura J Smith, Greg L Beilhartz, Laura C Bahlmann, Emma Jameson, Roman A Melnyk, Molly S Shoichet
Attenuated diphtheria toxin mediates siRNA delivery. Science advances 6 (18) (2020)
Vania Vidimar, Greg L Beilhartz, Minyoung Park, Marco Biancucci, Matthew B Kieffer, David R Gius, Roman A Melnyk, Karla J F Satchell
An engineered chimeric toxin that cleaves activated mutant and wild-type RAS inhibits tumor growth. Proceedings of the National Academy of Sciences of the United States of America 117 (29) (2020)
Seiji N Sugiman-Marangos, Greg L Beilhartz, Xiaochu Zhao, Dongxia Zhou, Rong Hua, Peter Kijun Kim, James M Rini, Berge A Minassian, Roman A Melnyk
Exploiting the diphtheria toxin internalization receptor enhances delivery of proteins to lysosomes for enzyme replacement therapy. Science advances 6 (50) (2020)